Our Partners
At Neuronostics we value collaboration and believe that it’s a prerequisite for making a tangible difference. We listen to the diverse views of people with lived experience, the healthcare sector, researchers and charities across the globe to understand what needs to change and how we can achieve it together.
Commercial Partners
Working alongside our commercial partners, we accelerate innovation and expand the reach of our digital biomarker technology, ensuring it delivers value to healthcare providers and patients alike.



Clinical Partners
Our clinical partners help us to understand what needs to change and how we can help support healthcare services. Their perspectives are critical to inform our work. Our clinical trials are conducted in partnership with healthcare providers globally, to test the effectiveness and value of our products.













Academic Partners
We collaborate with our academic partners on a range of research projects which underpin the development of our novel biomarkers and technology.






Charity Partners
We work closely with our charity partners on raising awareness of neurological conditions and with their user groups to trial our technology. They importantly help us communicate with the lived experience community.



Investors
We collaborate with our investor partners on strategic aims and progress towards key company milestones. Our investors include:




Become a partner
Interested in working together?
We are interested in partnering with academic researchers, healthcare professionals, industry, and people with lived experience of Epilepsy, to validate and translate novel biomarkers for neurological conditions, co-develop technologies to solve real-world problems, and trial products in real world settings.